Trial intelligence / Profile preview

Gastromotal breath test to identify dyspeptic patients who benefit from domperidone

2011-002782-38Phase 2Active

Sponsor
INFAI
Start
Apr 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of domperidone in dyspepsia and gastroparesis (2 cohorts), sponsored by INFAI. Started Apr 2012; status: active.

02

Drugs

domperidone
03

Conditions

dyspepsiagastroparesis

Beyond the preview

Go deeper on 2011-002782-38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-002782-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call